Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E13.58 EPS (ttm)3.57 Insider Own- Shs Outstand2.41B Perf Week-3.14%
Market Cap116.88B Forward P/E12.72 EPS next Y3.81 Insider Trans- Shs Float2.42B Perf Month-9.37%
Income8.73B PEG1.76 EPS next Q- Inst Own10.70% Short Float0.42% Perf Quarter-11.44%
Sales43.89B P/S2.66 EPS this Y22.70% Inst Trans0.35% Short Ratio3.60 Perf Half Y-4.51%
Book/sh4.72 P/B10.27 EPS next Y12.72% ROA17.30% Target Price58.67 Perf Year0.04%
Cash/sh2.54 P/C19.05 EPS next 5Y7.70% ROE110.00% 52W Range47.23 - 55.95 Perf YTD-6.93%
Dividend2.56 P/FCF47.05 EPS past 5Y4.60% ROI24.90% 52W High-13.37% Beta0.57
Dividend %5.28% Quick Ratio0.80 Sales past 5Y1.70% Gross Margin69.60% 52W Low2.62% ATR0.75
Employees99451 Current Ratio1.10 Sales Q/Q-10.30% Oper. Margin31.70% RSI (14)24.35 Volatility1.14% 0.95%
OptionableYes Debt/Eq2.61 EPS Q/Q-30.90% Profit Margin27.90% Rel Volume1.38 Prev Close48.03
ShortableYes LT Debt/Eq2.32 EarningsFeb 03 Payout52.60% Avg Volume2.85M Price48.47
Recom2.20 SMA20-7.77% SMA50-9.38% SMA200-7.82% Volume3,927,911 Change0.92%
23-Apr-14Upgrade Argus Hold → Buy
28-May-13Upgrade Deutsche Bank Hold → Buy
11-Jan-11Upgrade Jefferies Hold → Buy
02-Jun-10Upgrade Jefferies Hold → Buy
16-Feb-10Upgrade JP Morgan Underweight → Neutral $26
13-Jan-10Downgrade Credit Suisse Outperform → Underperform
24-Nov-09Initiated Leerink Swann Mkt Perform
16-Nov-09Initiated Deutsche Securities Hold
12-Nov-09Initiated Barclays Capital Equal Weight
23-Oct-09Downgrade Jefferies & Co Buy → Hold
17-Mar-09Initiated Credit Suisse Outperform
26-Jan-09Initiated Jefferies & Co Buy
14-Nov-08Downgrade UBS Buy → Neutral
18-Apr-08Downgrade JP Morgan Neutral → Underweight
11-Feb-08Upgrade UBS Neutral → Buy
01-Feb-08Upgrade HSBC Securities Underweight → Neutral
24-Oct-07Initiated Bernstein Mkt Perform
06-Sep-07Initiated UBS Neutral
25-Jul-07Downgrade Bear Stearns Peer Perform → Underperform
25-May-07Reiterated Banc of America Sec Neutral $62 → $57
30-Jul-14 06:00PM  Why There's Far More To Pfizer Than Viagra at Investopedia
05:20AM  AstraZeneca to Pay Up to $2.1 Billion For Respiratory Drugs at New York Times
05:20AM  AstraZeneca to Pay Almirall Up to $2.1 Billion for Respiratory Drugs at New York Times
29-Jul-14 03:31PM  GSK's Tanzeum is now available in pharmacies in the U.S. PR Newswire
08:21AM  What You Were Buying Last Week: GlaxoSmithKline plc at Motley Fool
28-Jul-14 10:53PM  [$$] Investigators Tied to GSK Get Trial Date at The Wall Street Journal
05:30PM  Novartis Division Gets European Approval for Simbrinza Zacks
11:33AM  Will GlaxoSmithKline plc Split Itself In Two? at Motley Fool
09:47AM  Glaxo Has No Plans to Spin Off Consumer Health-Care Division at Bloomberg
08:47AM  Why GlaxoSmithKline (GSK) Stock Is Higher Today at TheStreet
03:43AM  The FTSE 100's Hottest Dividend Picks: GlaxoSmithKline plc at Motley Fool
25-Jul-14 12:57PM  3 Shares That Can Benefit From A Resurgent UK Economy at Motley Fool
11:18AM  Baksheesh? Glaxo Allegedly Paid Bribes in Syria, too, a Report Says at The Wall Street Journal
09:54AM  Today's Top Health Care Headlines: AbbVie and GlaxoSmithKline at Motley Fool
08:18AM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
07:50AM  The Buy Case For GlaxoSmithKline plc Is Getting Stronger Every Day at Motley Fool
07:47AM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
06:58AM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
06:47AM  Don't Panic, Dividends Are Doing Fine at Motley Fool
04:38AM  Glaxo Investigates Allegations of Bribery in Syria at Bloomberg
12:01AM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
24-Jul-14 11:02PM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
10:55PM  UCB's Brivaracetam Positive in Phase III Epilepsy Study Zacks
09:07PM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
06:57PM  GlaxoSmithKline Investor's Business Daily
06:13PM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
05:29PM  [$$] Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
04:40PM  Can GlaxoSmithKlines Slumping Stock Recover? at Wall St. Cheat Sheet
04:32PM  Were There Any Silver Linings in GlaxoSmithKline Stock's Earnings Failure? at Motley Fool
02:05PM  3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences, and GlaxoSmithKline at Motley Fool
01:32PM  FDA Approves FlonaseĀ® Allergy Relief For Sale Over-The-Counter In The United States PR Newswire
01:11PM  [$$] Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
12:15PM  [$$] Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
10:20AM  Glaxo (GSK) Slips on Disappointing Q2 Earnings, Cuts View Zacks
09:00AM  3 Positives From This Week's GlaxoSmithKline plc Results at Motley Fool
07:55AM  Glaxo Seeks Approval for Worlds First Malaria Vaccine at Bloomberg
06:54AM  GlaxoSmithKline Slumps: GSK Falls 5.9% in Session Zacks
04:11AM  Is GlaxoSmithKline plc A Safe Dividend Investment? at Motley Fool
12:25AM  [$$] GlaxoSmithKline Reduces Full-Year Earnings Forecast at The Wall Street Journal
23-Jul-14 10:40PM  [$$] GlaxoSmithKline Reduces Full-Year Earnings Forecast at The Wall Street Journal -5.98%
09:00PM  Glaxosmithkline Reports Weak Sales and Cuts Outlook at New York Times
09:00PM  Glaxosmithkline Reports Weak Sales and Cuts Outlook at New York Times
08:51PM  [$$] GlaxoSmithKline Reduces Full-Year Earnings Forecast at The Wall Street Journal
08:05PM  Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom at TheStreet
07:35PM  Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom at TheStreet
07:01PM  Glaxos Witty Has Bigger Problem Than China as Sales Sag at Bloomberg
04:19PM  Is Inovio Undervalued After Positive HPV Therapy Results? at Seeking Alpha
01:08PM  China Bribery Probe, Dismal Advair Sales Leave Glaxo Shares Gasping at Forbes
12:56PM  Why GlaxoSmithKline (GSK) Stock Continues To Sink Today at TheStreet
12:32PM  [video] GlaxoSmithKline Cuts Full-Year Outlook as Weak Advair Sales Weigh at TheStreet
11:58AM  Glaxo slides in London after earnings warning at MarketWatch
11:37AM  [$$] Glaxo Reduces Earnings Forecast at The Wall Street Journal
11:31AM  [$$] U.S. Takes Wind Out of Glaxo's Sales at The Wall Street Journal
11:31AM  Europe closes higher despite Ukraine tensions at CNBC
10:30AM  Should You Buy GlaxoSmithKline plc Or AstraZeneca plc? at Motley Fool
10:13AM  Europe up despite Ukraine tensions; GSK slumps at CNBC
10:01AM  Glaxo shares fall in London after earnings warning at MarketWatch
09:55AM  Europe up amid Ukraine tensions; AkzoNobel bounces at CNBC
09:52AM  [$$] Glaxo Reduces Earnings Forecast at The Wall Street Journal
09:27AM  Glaxo Cuts 2014 Forecast on Sluggish U.S. Drug Sales at Bloomberg
09:05AM  [$$] Glaxo Reduces Earnings Forecast at The Wall Street Journal
09:00AM  Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising at Investor's Business Daily
08:58AM  Why GlaxoSmithKline (GSK) Stock Is Falling Today at TheStreet
08:32AM  GlaxoSmithKline plc Falls On Drop In Profits And Turnover at Motley Fool
07:52AM  Europe higher amid Ukraine tensions; Deutsche Bank falls at CNBC
07:37AM  GSK CEO and CFO Interviewed on Q2 2014 Results and Strategy Update PR Newswire
07:15AM  Glaxo Profit Falls on Sluggish U.S. Respiratory Sales at Bloomberg
06:59AM  GSK stock plunges as earnings forecast slashed at CNBC
06:59AM  GSK CEO: 'Very committed' to China despite probe at CNBC
04:33AM  Europe higher amid Ukraine tensions; Deutsche Bank falls at CNBC
03:26AM  Europe shares fluctuate amid Ukraine tensions at CNBC
12:55AM  Europe shares seen lower after Russia sanctions at CNBC
22-Jul-14 11:30AM  What To Buy: Top 3 Buy-Rated Dividend Stocks: STWD, ESV, GSK at TheStreet
09:32AM  Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings at Motley Fool
21-Jul-14 10:40AM  Eyes Down For GlaxoSmithKline plc Results at Motley Fool
09:53AM  3 Household-Name Stocks With Dividend Yields Over 3% And P/E Ratios Under 15 at Seeking Alpha
09:53AM  5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise at Seeking Alpha
18-Jul-14 09:15AM  [video] Europes Week Ahead: BOE in Rate-Rise Debate at MarketWatch
17-Jul-14 10:18AM  3 Things That Say GlaxoSmithKline plc Is A Buy at Motley Fool
08:46AM  Today's Top Health Care Stocks to Watch: AbbVie, GlaxoSmithKline, and Shire at Motley Fool
05:09AM  Is GlaxoSmithKline plc The World's Most Undervalued Company? at Motley Fool
04:58AM  GSK confirms it fired staff for corruption in China in 2001 Reuters
04:08AM  Glaxo Fired Employees in 2001 After China Bribery Probe at Bloomberg
16-Jul-14 05:42PM  Theravance/Glaxo Commence Global Late stage Study on COPD Zacks
10:39AM  The Risks Of Investing In GlaxoSmithKline Plc at Motley Fool
02:24AM  GSK and Theravance Announce Initiation of Phase III Programme With Fixed Dose Triple Combination Treatment FF/UMEC/VI in Patients With COPD Marketwired
15-Jul-14 05:36PM  Time to Fall Back in Love With Exelixis Inc.? at Motley Fool
14-Jul-14 11:40AM  China indicts U.S., British corporate investigators at USA TODAY
11:32AM  China Reveals Charges in Glaxo Case for a British-American Couple at New York Times
11:32AM  China Reveals Charges for British-American Couple in Case Involving Glaxo at New York Times
11:05AM  After Another Shire PLC Bid, Could AstraZeneca plc Or GlaxoSmithKline plc Be Next? at Motley Fool
10:24AM  How Will GlaxoSmithKline (GSK) Stock Be Impacted By China Investigation? at TheStreet
13-Jul-14 11:39PM  China indicts U.S., British corporate investigators at USA TODAY
11-Jul-14 02:00PM  A Global Pharma Boom Is Coming... Here's How To Profit StreetAuthority Network
06:52AM  [video] Big pharma's big battle with Alzheimer's at CNBC
10-Jul-14 02:18PM  Better Buy: GlaxoSmithKline vs. AstraZeneca at Motley Fool
02:12PM  Evaluating GlaxoSmithKline's Dividend at Seeking Alpha
02:10AM  Summer Selection: Tobacco, Pharma Or Retail Stocks? at Motley Fool
09-Jul-14 06:27AM  2 Dividend Champions Trading At Rock-Bottom Levels: HSBC Holdings plc And GlaxoSmithKline plc at Motley Fool
08-Jul-14 05:27PM  GlaxoSmithKline Is Moving Forward After Woeful Performance at Seeking Alpha
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company's nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. The company has a strategic cancer immunotherapy collaboration with Adaptimmune Limited to develop and commercialize NY-ESO-1 clinical cancer program. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerMay 09Buy8544835.30317,7702,715,292,313,28130,576,072May 13 04:43 PM
GLAXOSMITHKLINE PLC10% OwnerApr 01Buy12.00103,7621,245,1441,989,598Apr 02 12:42 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerFeb 19Buy14.0035,000490,0001,356,533Feb 20 06:56 PM
GLAXOSMITHKLINE PLC10% OwnerFeb 11Buy12850698.95342,2294,397,881,850,96030,258,302Feb 13 04:41 PM
GLAXOSMITHKLINE PLCFormer 10% ShareholderFeb 10Buy12.00143,7731,725,276143,773Feb 12 05:56 PM
GLAXOSMITHKLINE PLC10% OwnerOct 29Buy4913613.18130,473641,093,852,43429,916,073Oct 29 05:37 PM